Brian Adams
Fortuna: 10 M $ al 30/09/2026
Fortuna: 10 M $ al 30/09/2026
Brian R.
Adams is Secretary & Chief Legal Officer at Kymera Therapeutics, Inc. since 2025.
Formerly, Mr. Adams was Secretary & General Counsel at Relay Therapeutics, Inc. from 2018 to 2022, Secretary, Senior Vice President & General Counsel at Keryx Biopharmaceuticals, Inc. from 2014 to 2018, and General Counsel at Algeta ASA from 2012 to 2014.
Mr. Adams completed undergraduate studies at Harvard University and graduate studies at Columbus School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/09/2026 | 50.254 ( 0,06 % ) | 6 M $ | 30/09/2026 | |
| 31/03/2026 | 226.861 ( 0,1 % ) | 4 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Consejero General | 03/09/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Consejero General | 13/03/2018 |
| ALGETA ASA | Consejero General | 01/03/2014 |
| RELAY THERAPEUTICS, INC. | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.